11 November 2012

The MedDRA Management Board met in San Diego, CA, USA on 10-11 November 2012.

The Board is pleased to announce that, for the eighth year in a row, there will be no increase in MedDRA subscription rates for 2013. This is the result of continued growth of MedDRA subscribers throughout the world and increased efficiencies to contain costs of maintenance and development of the terminology.

For the sixth time, the MedDRA Management Board welcomed the Regional Harmonisation Initiative and Drug Regulatory Authority/Department of Health members of the ICH Global Cooperation Group to a special session. During this special session, the Board and the invited guests heard from representatives of various regulatory authorities who described their experiences with the implementation of MedDRA and the use of MedDRA for data analysis.


See the complete press release